Consolidated Statement of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Common Stock Issuable	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 11	$ 44,834	$ 50	$ (9)	$ (21,276)	$ 23,610
Balance (in Shares) at Dec. 31, 2019	10,770,948
Issuance of common stock for cash, net	$ 2	24,905				24,907
Issuance of common stock for cash, net (in Shares)	2,874,600
Acquisition and retirement of common stock		(1,012)				(1,012)
Acquisition and retirement of common stock (in Shares)	(220,000)
Capital contribution		216				216
Cashless exercise of warrants
Cashless exercise of warrants (in Shares)	2,400
Issuance of common stock issuable		50	(50)
Issuance of common stock issuable (in Shares)	33,335
Stock-based compensation		3,112				3,112
Stock-based compensation (in Shares)	20,000
Gain (loss) on foreign currency translation				20		20
Net loss					(12,099)	(12,099)
Balance at Dec. 31, 2020	$ 13	72,105		11	(33,375)	38,754
Balance (in Shares) at Dec. 31, 2020	13,481,283
Issuance of common stock for cash, net	$ 5	80,248				80,253
Issuance of common stock for cash, net (in Shares)	3,970,854
Settlement of Xencor warrant for cash and common stock		(15,000)				(15,000)
Settlement of Xencor warrant for cash and common stock (in Shares)	192,533
Warrants issued to lenders as debt inducement		619				619
Exercise of warrants		18				18
Exercise of warrants (in Shares)	15,633
Exercise of stock options		1,135				1,135
Exercise of stock options (in Shares)	183,000
Stock-based compensation		4,796				4,796
Gain (loss) on foreign currency translation				(10)		(10)
Net loss					(30,340)	(30,340)
Balance at Dec. 31, 2021	$ 18	$ 143,921		$ 1	$ (63,715)	$ 80,225
Balance (in Shares) at Dec. 31, 2021	17,843,303